Sleep in Collegiate Baseball Players
Assessing and Optimizing Sleep, Diet, and Performance in Columbia University Baseball Players
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Collegiate baseball player at Columbia University
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Sleep & diet intervention
Participants will be asked to increase their fruit and vegetable consumption, time in bed, and modify light exposure across the day
|
Participants will be asked to increase their fruit and vegetable consumption, time in bed, and modify light exposure across the day
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Athletic performance (position-specific for batters and pitchers)
Time Frame: pre and post intervention (4-6 weeks)
|
Batters: Baseball radar gun, outcome is exit velocity (speed at which ball leaves the bat, in miles/h) Pitchers: Baseball radar gun measuring velocity (miles/h)
|
pre and post intervention (4-6 weeks)
|
|
Sleep quality
Time Frame: Nightly for 6 weeks
|
Duration (h:min)
|
Nightly for 6 weeks
|
|
Sleep quality
Time Frame: Nightly for 6 weeks
|
Sleep stage (%REM, %Deep sleep)
|
Nightly for 6 weeks
|
|
Dietary quality
Time Frame: pre and post intervention (4-6 weeks)
|
3-day food recalls (ASA-24)
|
pre and post intervention (4-6 weeks)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Generalized Anxiety Disorder (GAD-7)
Time Frame: pre and post intervention (4-6 weeks)
|
7 questions, 0-3 points each (not at all to nearly every day); global score 0-21, higher score is worse
|
pre and post intervention (4-6 weeks)
|
|
Patient Health Questionnaire-9
Time Frame: pre and post intervention (4-6 weeks)
|
9 questions, 0-3 points each (not at all to nearly every day); global score 0-27, higher score is worse
|
pre and post intervention (4-6 weeks)
|
|
Sport Anxiety Scale-2
Time Frame: pre and post intervention (4-6 weeks)
|
4-point Likert scale (not at all to very much); global score 5-20, higher score is worse
|
pre and post intervention (4-6 weeks)
|
|
Pitching accuracy
Time Frame: pre and post intervention (4-6 weeks)
|
Ratio of strikes to balls (pitchers only)
|
pre and post intervention (4-6 weeks)
|
|
Isometric wall push
Time Frame: pre and post intervention (4-6 weeks)
|
Hand-held dynamometer (pounds) (pitchers only)
|
pre and post intervention (4-6 weeks)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Marie-Pierre St-Onge, Columbia University Vagelos College of Physicians & Surgeons
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AAAV4501
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.